{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T14:24:32Z","timestamp":1791815072972,"version":"4.3.4"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T00:00:00Z","timestamp":1779321600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T00:00:00Z","timestamp":1784073600000},"content-version":"vor","delay-in-days":55,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100018571","name":"Guangxi Science and Technology Base and Talent Special Project","doi-asserted-by":"crossref","award":["GUI KE AD22035047"],"award-info":[{"award-number":["GUI KE AD22035047"]}],"id":[{"id":"10.13039\/501100018571","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Key R&D Program of Scientific Research and Technology Development Project of Guangxi","award":["GUI KE AB23026078"],"award-info":[{"award-number":["GUI KE AB23026078"]}]},{"name":"Joint Project on Regional High-Incidence Diseases Research of Guangxi Natural Science Foundation under Grant","award":["2023GXNSFBA026202"],"award-info":[{"award-number":["2023GXNSFBA026202"]}]},{"name":"Guangxi Medical and Health Key Discipline Construction Proiect.","award":["Guangxi Medical and Health Key Discipline Construction Proiect."],"award-info":[{"award-number":["Guangxi Medical and Health Key Discipline Construction Proiect."]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"DOI":"10.1186\/s12967-026-07859-y","type":"journal-article","created":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T16:35:13Z","timestamp":1779381313000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Human mesenchymal stem cell-derived miR-3614-5p exosomes suppress progression of colorectal cancer by targeting IL7R\u03b1"],"prefix":"10.1186","volume":"24","author":[{"given":"Mengling","family":"Ye","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingzhen","family":"Bian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanyan","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shirong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lixia","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinlu","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuxuan","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shufang","family":"Ning","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuyang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinglei","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinxing","family":"Lei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-8406-9801","authenticated-orcid":false,"given":"Litu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,21]]},"reference":[{"key":"7859_CR1","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1038\/s41575-021-00569-4","volume":"19","author":"K Ganesh","year":"2022","unstructured":"Ganesh K. Optimizing immunotherapy for colorectal cancer. Nat Rev Gastroenterol Hepatol. 2022;19:93\u20134. https:\/\/doi.org\/10.1038\/s41575-021-00569-4.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"7859_CR2","doi-asserted-by":"publisher","first-page":"372","DOI":"10.3322\/caac.21728","volume":"72","author":"F Ciardiello","year":"2022","unstructured":"Ciardiello F, Ciardiello D, Martini G, Napolitano S, Tabernero J, Cervantes A. Clinical management of metastatic colorectal cancer in the era of precision medicine. CA Cancer J Clin. 2022;72:372\u2013401. https:\/\/doi.org\/10.3322\/caac.21728.","journal-title":"CA Cancer J Clin"},{"key":"7859_CR3","doi-asserted-by":"publisher","unstructured":"Aparicio J, Esposito F, Serrano S, Falco E, Escudero P, Ruiz-Casado A, Manzano H, Fernandez-Montes A. Metastatic colorectal cancer: first line therapy for unresectable disease. J Clin Med. 2020;9. https:\/\/doi.org\/10.3390\/jcm9123889.","DOI":"10.3390\/jcm9123889"},{"key":"7859_CR4","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1093\/nar\/gkab1256","volume":"50","author":"A Kilikevicius","year":"2022","unstructured":"Kilikevicius A, Meister G, Corey DR. Reexamining assumptions about miRNA-guided gene Silencing. Nucleic Acids Res. 2022;50:617\u201334. https:\/\/doi.org\/10.1093\/nar\/gkab1256.","journal-title":"Nucleic Acids Res"},{"key":"7859_CR5","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.canlet.2020.12.025","volume":"501","author":"X Huang","year":"2021","unstructured":"Huang X, Zhu X, Yu Y, Zhu W, Jin L, Zhang X, Li S, Zou P, Xie C, Cui R. Dissecting MiRNA signature in colorectal cancer progression and metastasis. Cancer Lett. 2021;501:66\u201382. https:\/\/doi.org\/10.1016\/j.canlet.2020.12.025.","journal-title":"Cancer Lett"},{"key":"7859_CR6","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1038\/s41419-020-02900-4","volume":"11","author":"F Li","year":"2020","unstructured":"Li F, Yang H, Kong T, Chen S, Li P, Chen L, Cheng J, Cui G, Zhang G. PGAM1, regulated by miR-3614-5p, functions as an oncogene by activating transforming growth factor-beta (TGF-beta) signaling in the progression of non-small cell lung carcinoma. Cell Death Dis. 2020;11:710. https:\/\/doi.org\/10.1038\/s41419-020-02900-4.","journal-title":"Cell Death Dis"},{"key":"7859_CR7","doi-asserted-by":"publisher","first-page":"114270","DOI":"10.1016\/j.ecoenv.2022.114270","volume":"247","author":"Y Yue","year":"2022","unstructured":"Yue Y, Tan M, Luo Y, Deng P, Wang H, Li J, Hao R, Tian L, Xie J, Chen M, et al. miR-3614-5p downregulation promotes cadmium-induced breast cancer cell proliferation and metastasis by targeting TXNRD1. Ecotoxicol Environ Saf. 2022;247:114270. https:\/\/doi.org\/10.1016\/j.ecoenv.2022.114270.","journal-title":"Ecotoxicol Environ Saf"},{"key":"7859_CR8","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/s13062-021-00312-8","volume":"16","author":"Z Feng","year":"2021","unstructured":"Feng Z, Ye Z, Xie J, Chen W, Li W, Xing C. Study on the mechanism of LOXL1-AS1\/miR-3614-5p\/YY1 signal axis in the malignant phenotype regulation of hepatocellular carcinoma. Biol Direct. 2021;16:24. https:\/\/doi.org\/10.1186\/s13062-021-00312-8.","journal-title":"Biol Direct"},{"key":"7859_CR9","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1002\/mc.23523","volume":"62","author":"H Yao","year":"2023","unstructured":"Yao H, Zhou X, Zhou A, Chen J, Chen G, Shi X, Shi B, Tai Q, Mi X, Zhou G, et al. RFC5, regulated by circ_0038985\/miR-3614-5p, functions as an oncogene in the progression of colorectal cancer. Mol Carcinog. 2023;62:771\u201385. https:\/\/doi.org\/10.1002\/mc.23523.","journal-title":"Mol Carcinog"},{"key":"7859_CR10","doi-asserted-by":"publisher","first-page":"666833","DOI":"10.3389\/fgene.2021.666833","volume":"12","author":"L Han","year":"2021","unstructured":"Han L, Sun Y, Lu C, Ma C, Shi J, Sun D. MiR-3614-5p is a potential novel biomarker for colorectal cancer. Front Genet. 2021;12:666833. https:\/\/doi.org\/10.3389\/fgene.2021.666833.","journal-title":"Front Genet"},{"key":"7859_CR11","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1038\/s41392-023-01704-0","volume":"9","author":"F Tan","year":"2024","unstructured":"Tan F, Li X, Wang Z, Li J, Shahzad K, Zheng J. Clinical applications of stem cell-derived exosomes. Signal Transduct Target Ther. 2024;9:17. https:\/\/doi.org\/10.1038\/s41392-023-01704-0.","journal-title":"Signal Transduct Target Ther"},{"key":"7859_CR12","doi-asserted-by":"publisher","unstructured":"Kalluri R, LeBleu VS. The biology, function, and biomedical applications of exosomes. Science. 2020;367. https:\/\/doi.org\/10.1126\/science.aau6977.","DOI":"10.1126\/science.aau6977"},{"key":"7859_CR13","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1186\/s13045-021-01141-y","volume":"14","author":"Z Weng","year":"2021","unstructured":"Weng Z, Zhang B, Wu C, Yu F, Han B, Li B, Li L. Therapeutic roles of mesenchymal stem cell-derived extracellular vesicles in cancer. J Hematol Oncol. 2021;14:136. https:\/\/doi.org\/10.1186\/s13045-021-01141-y.","journal-title":"J Hematol Oncol"},{"key":"7859_CR14","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1016\/j.ejca.2003.10.016","volume":"40","author":"MA Al-Rawi","year":"2004","unstructured":"Al-Rawi MA, Rmali K, Watkins G, Mansel RE, Jiang WG. Aberrant expression of interleukin-7 (IL-7) and its signalling complex in human breast cancer. Eur J Cancer. 2004;40:494\u2013502. https:\/\/doi.org\/10.1016\/j.ejca.2003.10.016.","journal-title":"Eur J Cancer"},{"key":"7859_CR15","doi-asserted-by":"publisher","first-page":"e12699","DOI":"10.1111\/cpr.12699","volume":"52","author":"L Shi","year":"2019","unstructured":"Shi L, Xu Z, Yang Q, Huang Y, Gong Y, Wang F, Ke B. IL-7-Mediated IL-7R-JAK3\/STAT5 signalling pathway contributes to chemotherapeutic sensitivity in non-small-cell lung cancer. Cell Prolif. 2019;52:e12699. https:\/\/doi.org\/10.1111\/cpr.12699.","journal-title":"Cell Prolif"},{"key":"7859_CR16","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/j.intimp.2016.08.017","volume":"40","author":"H Qu","year":"2016","unstructured":"Qu H, Zou Z, Pan Z, Zhang T, Deng N, Chen G, Wang Z. IL-7\/IL-7 receptor axis stimulates prostate cancer cell invasion and migration via AKT\/NF-kappaB pathway. Int Immunopharmacol. 2016;40:203\u201310. https:\/\/doi.org\/10.1016\/j.intimp.2016.08.017.","journal-title":"Int Immunopharmacol"},{"key":"7859_CR17","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1007\/s00262-016-1933-3","volume":"66","author":"M Krzystek-Korpacka","year":"2017","unstructured":"Krzystek-Korpacka M, Zawadzki M, Neubauer K, Bednarz-Misa I, Gorska S, Wisniewski J, Witkiewicz W, Gamian A. Elevated systemic interleukin-7 in patients with colorectal cancer and individuals at high risk of cancer: association with lymph node involvement and tumor location in the right colon. Cancer Immunol Immunother. 2017;66:171\u20139. https:\/\/doi.org\/10.1007\/s00262-016-1933-3.","journal-title":"Cancer Immunol Immunother"},{"issue":"2","key":"7859_CR18","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1046\/j.1365-3083.1997.d01-384.x","volume":"45","author":"JT Barata","year":"1997","unstructured":"Barata JT, Silva A, Fau - Abecasis M, Abecasis M, Fau - Carlesso N, Carlesso N, Fau - Cumano A, Cumano A. Fau - cardoso AA and cardoso AA. Molecular and functional evidence for activity of murine IL-7 on human lymphocytes. Scand J Immunol. 1997;45(2):182\u201392. https:\/\/doi.org\/10.1046\/j.1365-3083.1997.d01-384.x.","journal-title":"Scand J Immunol"},{"issue":"2","key":"7859_CR19","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1046\/j.1365-3083.1997.d01-384.x","volume":"45","author":"YJ Zhu","year":"1997","unstructured":"Zhu YJ, Li X, Chen TT, Wang JX, Zhou YX, Mu XL, Du Y, Wang JL, Tang J, Liu JY. Personalised neoantigen-based therapy in colorectal cancer. Scand J Immunol. 1997;45(2):182\u201392. https:\/\/doi.org\/10.1046\/j.1365-3083.1997.d01-384.x.","journal-title":"Scand J Immunol"},{"key":"7859_CR20","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1001\/jama.2021.0106","volume":"325","author":"LH Biller","year":"2021","unstructured":"Biller LH, Schrag D. Diagnosis and treatment of metastatic colorectal cancer: A review. JAMA. 2021;325:669\u201385. https:\/\/doi.org\/10.1001\/jama.2021.0106.","journal-title":"JAMA"},{"key":"7859_CR21","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1038\/s41575-019-0230-y","volume":"17","author":"G Jung","year":"2020","unstructured":"Jung G, Hernandez-Illan E, Moreira L, Balaguer F, Goel A. Epigenetics of colorectal cancer: biomarker and therapeutic potential. Nat Rev Gastroenterol Hepatol. 2020;17:111\u201330. https:\/\/doi.org\/10.1038\/s41575-019-0230-y.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"7859_CR22","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1002\/cac2.12149","volume":"41","author":"H Li","year":"2021","unstructured":"Li H, Liang J, Wang J, Han J, Li S, Huang K, Liu C. Mex3a promotes oncogenesis through the RAP1\/MAPK signaling pathway in colorectal cancer and is inhibited by hsa-miR-6887-3p. Cancer Commun (Lond). 2021;41:472\u201391. https:\/\/doi.org\/10.1002\/cac2.12149.","journal-title":"Cancer Commun (Lond)"},{"key":"7859_CR23","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1186\/s12943-022-01650-5","volume":"21","author":"Z Lin","year":"2022","unstructured":"Lin Z, Wu Y, Xu Y, Li G, Li Z, Liu T. Mesenchymal stem cell-derived exosomes in cancer therapy resistance: recent advances and therapeutic potential. Mol Cancer. 2022;21:179. https:\/\/doi.org\/10.1186\/s12943-022-01650-5.","journal-title":"Mol Cancer"},{"key":"7859_CR24","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.smim.2017.12.003","volume":"35","author":"TL Whiteside","year":"2018","unstructured":"Whiteside TL. Exosome and mesenchymal stem cell cross-talk in the tumor microenvironment. Semin Immunol. 2018;35:69\u201379. https:\/\/doi.org\/10.1016\/j.smim.2017.12.003.","journal-title":"Semin Immunol"},{"key":"7859_CR25","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1186\/s13287-022-02811-5","volume":"13","author":"G Guo","year":"2022","unstructured":"Guo G, Tan Z, Liu Y, Shi F, She J. The therapeutic potential of stem cell-derived exosomes in the ulcerative colitis and colorectal cancer. Stem Cell Res Ther. 2022;13:138. https:\/\/doi.org\/10.1186\/s13287-022-02811-5.","journal-title":"Stem Cell Res Ther"},{"key":"7859_CR26","doi-asserted-by":"publisher","first-page":"2001334","DOI":"10.1002\/advs.202001334","volume":"7","author":"M Zhai","year":"2020","unstructured":"Zhai M, Zhu Y, Yang M, Mao C. Human mesenchymal stem cell derived exosomes enhance cell-Free bone regeneration by altering their MiRNAs profiles. Adv Sci (Weinh). 2020;7:2001334. https:\/\/doi.org\/10.1002\/advs.202001334.","journal-title":"Adv Sci (Weinh)"},{"key":"7859_CR27","doi-asserted-by":"publisher","first-page":"122214","DOI":"10.1016\/j.ijpharm.2022.122214","volume":"627","author":"B Jahangiri","year":"2022","unstructured":"Jahangiri B, Khalaj-Kondori M, Asadollahi E, Purrafee Dizaj L, Sadeghizadeh M. MSC-Derived exosomes suppress colorectal cancer cell proliferation and metastasis via miR-100\/mTOR\/miR-143 pathway. Int J Pharm. 2022;627:122214. https:\/\/doi.org\/10.1016\/j.ijpharm.2022.122214.","journal-title":"Int J Pharm"},{"issue":"38","key":"7859_CR28","doi-asserted-by":"publisher","first-page":"33681","DOI":"10.1021\/acsnano.5c05416","volume":"19","author":"Z Lv","year":"2025","unstructured":"Lv Z, Xu J, Cai X, Wang YA-O, Yang X, Wang H, Zhu YA-O, Feng B, Weng XA-O. Exosome-Based therapeutics for musculoskeletal disorders: advances in Engineering, Targeting, and biomaterial integration. ACS Nano. 2025;19(38):33681\u2013716. https:\/\/doi.org\/10.1021\/acsnano.5c05416.","journal-title":"ACS Nano"},{"issue":"4","key":"7859_CR29","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1038\/s12276-024-01201-6","volume":"56","author":"HI Kim","year":"2024","unstructured":"Kim HI, Park J, Zhu Y, Wang X, Han Y, Zhang DA-O. Recent advances in extracellular vesicles for therapeutic cargo delivery. Exp Mol Med. 2024;56(4):836\u201349. https:\/\/doi.org\/10.1038\/s12276-024-01201-6.","journal-title":"Exp Mol Med"},{"issue":"12","key":"7859_CR30","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1038\/s41419-024-07297-y","volume":"15","author":"Y Wu","year":"2024","unstructured":"Wu Y, Zhang J, Li G, Wang L, Zhao Y, Zheng B, Lin F, Xie L. Exosomal miR-320d promotes angiogenesis and colorectal cancer metastasis via targeting GNAI1 to affect the JAK2\/STAT3 signaling pathway. Cell Death Dis. 2024;15(12):913. https:\/\/doi.org\/10.1038\/s41419-024-07297-y.","journal-title":"Cell Death Dis"},{"issue":"2","key":"7859_CR31","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1046\/j.1365-3083.1997.d01-384.x","volume":"45","author":"MJ Maeurer","year":"1997","unstructured":"Maeurer MJ, Walter W, Fau - Martin D, Martin D, Fau - Zitvogel L, Zitvogel L, Fau - Elder E, Elder E, Fau - Storkus W, Storkus W. Fau - Lotze MT and Lotze MT. Interleukin-7 (IL-7) in colorectal cancer: IL-7 is produced by tissues from colorectal cancer and promotes Preferential expansion of tumour infiltrating lymphocytes. Scand J Immunol. 1997;45(2):182\u201392. https:\/\/doi.org\/10.1046\/j.1365-3083.1997.d01-384.x.","journal-title":"Scand J Immunol"},{"key":"7859_CR32","doi-asserted-by":"publisher","first-page":"47","DOI":"10.2147\/ITT.S264149","volume":"10","author":"PO Barros","year":"2021","unstructured":"Barros PO, Berthoud TK, Aloufi N, Angel JB. Soluble IL-7R\u03b1\/sCD127 in Health, Disease, and its potential role as a therapeutic agent. Immunotargets Ther. 2021;10:47\u201362. https:\/\/doi.org\/10.2147\/ITT.S264149.","journal-title":"Immunotargets Ther"},{"issue":"8","key":"7859_CR33","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1038\/s41419-020-02900-4","volume":"11","author":"F Li","year":"2020","unstructured":"Li F, Yang H, Kong T, Chen S, Li P, Chen L, Cheng J, Cui G, Zhang G. PGAM1, regulated by miR-3614-5p, functions as an oncogene by activating transforming growth factor-\u03b2 (TGF-\u03b2) signaling in the progression of non-small cell lung carcinoma. Cell Death Dis. 2020;11(8):710. https:\/\/doi.org\/10.1038\/s41419-020-02900-4.","journal-title":"Cell Death Dis"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12967-026-07859-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-026-07859-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-026-07859-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T05:00:22Z","timestamp":1784091622000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12967-026-07859-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,21]]},"references-count":33,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["7859"],"URL":"https:\/\/doi.org\/10.1186\/s12967-026-07859-y","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,21]]},"assertion":[{"value":"3 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was approved by the Ethics Committee of the Guangxi Medical University Affiliated Tumor Hospital.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All the authors agree to the content of the paper and consent for publication.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that there are no conflicts of interest.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"914"}}